Related Experiment Video

Updated: Jul 14, 2026

A Visual Description of the Dissection of the Cerebral Surface Vasculature and Associated Meninges and the Choroid Plexus from Rat Brain
12:31

A Visual Description of the Dissection of the Cerebral Surface Vasculature and Associated Meninges and the Choroid Plexus from Rat Brain

Published on: November 14, 2012

Methamphetamine and cardiovascular pathology: a review of the evidence

Sharlene Kaye1, Rebecca McKetin, Johan Duflou

  • 1National Drug and Alcohol Research Centre, University of New South Wales, Australia. s.kaye@med.unsw.edu.au

Addiction (Abingdon, England)
|June 15, 2007
PubMed

Insights

Methamphetamine use significantly elevates the risk of cardiovascular problems, including potentially fatal cardiac pathology. Chronic methamphetamine users face the greatest risk, which can lead to premature mortality.

Area of Science:

  • Cardiology
  • Toxicology
  • Public Health

Background:

  • Methamphetamine is a potent stimulant with known systemic effects.
  • Cardiovascular complications are a significant concern in methamphetamine users.

Purpose of the Study:

  • To review and synthesize existing literature on the cardiovascular effects of methamphetamine.
  • To discuss the implications of these effects for individuals using methamphetamine.

Main Methods:

  • Comprehensive literature search of MEDLINE and EMBASE databases.
  • Systematic review of identified studies on methamphetamine and cardiovascular health.

Main Results:

  • Evidence indicates methamphetamine causes adverse and potentially fatal cardiovascular effects.
  • Methamphetamine users exhibit an elevated risk of cardiac pathology, particularly chronic users.
  • Pre-existing conditions and concurrent substance use exacerbate cardiac risks.

Conclusions:

  • Methamphetamine use is strongly linked to increased cardiac pathology and risk of acute cardiac events.
  • The cardiovascular risks associated with methamphetamine use can be long-lasting and contribute to premature mortality.
  • Clinicians should be aware of these risks when managing methamphetamine users.
Abstract

Related Concept Videos

Stimulants01:29

Stimulants

Stimulants are substances that enhance neural activity and elevate dopamine levels in the brain, leading to their highly addictive nature. These drugs include cocaine, amphetamines, MDMA, caffeine, and nicotine, each with distinct mechanisms of action and varied health implications.
Cocaine can be administered via snorting, injection, or smoking. It primarily functions by blocking the reuptake of dopamine, resulting in a euphoric high characterized by an intense sensation of happiness and...
CNS Stimulants: Cocaine, Amphetamines and Cannabinoids01:24

CNS Stimulants: Cocaine, Amphetamines and Cannabinoids

CNS stimulants, such as cocaine, amphetamines, and cannabinoids, have varying structures and mechanisms of action that lead to different therapeutic effects and side effects. Cocaine, with its molecular formula C17H21NO4, is a tropane alkaloid and a tertiary amino compound. It has two chemical forms: the hydrochloride salt and the "freebase." The former is in powder form, while the latter involves removing the hydrochloride salt to create a form that can be smoked. Cocaine exerts its effects by...
Blood Studies for Cardiovascular System II: CRP, Hcy, and Cardiac Natriuretic Peptide Markers01:19

Blood Studies for Cardiovascular System II: CRP, Hcy, and Cardiac Natriuretic Peptide Markers

Cardiac biomarkers are critical in diagnosing, prognosing, and managing cardiovascular diseases. Routine measurement of specific biomarkers such as B-type natriuretic peptide (BNP), C-reactive protein (CRP), and homocysteine (Hcy) is common practice in clinical settings to evaluate heart function and predict cardiovascular events.
These markers indicate stress or strain on the heart muscle:
Natriuretic Peptides (BNP)
Cardiac myocytes produce these hormones in response to ventricular stretching...
Psychoneuroimmunology: Cardiovascular Disease01:27

Psychoneuroimmunology: Cardiovascular Disease

Psychoneuroimmunology (PNI) is a multidisciplinary field that examines how psychological factors, particularly stress, interact with the immune system and impact physical health. Research in PNI has shown that chronic or traumatic stress can disrupt both the hypothalamic-pituitary-adrenal axis and the sympathetic nervous system. These disruptions contribute to serious health conditions, including cardiovascular diseases.
A key area of focus in PNI is the relationship between stress and coronary...
Pathophysiology of Cardiac Performance01:29

Pathophysiology of Cardiac Performance

Typical heart performance is influenced by heart rate, rhythm, myocardial contraction, and metabolism or blood flow. The cardiac muscle exhibits distinct electrophysiological features, including pacemaker activity and calcium channel control, which play a vital role in the heart's response to various drugs. The autonomic nervous system, comprising the sympathetic and parasympathetic branches, regulates heart rate. Sympathetic activation increases heart rate, while parasympathetic activation...
Adrenergic Agonists: Mixed-Action Agents01:28

Adrenergic Agonists: Mixed-Action Agents

Mixed-action adrenergic agonists, like ephedrine and pseudoephedrine, directly and indirectly affect adrenergic receptors. These agents stimulate adrenoceptors and indirectly release stored neurotransmitters, amplifying the adrenergic response.
Ephedrine and pseudoephedrine lack a catecholamine group, making them less susceptible to degradation by metabolic enzymes. They have increased oral bioavailability and lipophilicity, resulting in a longer duration of action. Their response is reduced by...